Navigation Links
St. Jude Children's Research Hospital renewed as NCI-designated Comprehensive Cancer Center
Date:6/11/2014

(MEMPHIS, Tenn. June 11, 2014) St. Jude Children's Research Hospital's designation as a Comprehensive Cancer Center has been renewed by the National Cancer Institute (NCI), earning the highest possible score of "exceptional." St. Jude remains the first and only NCI-designated Comprehensive Cancer Center that is devoted solely to children. St. Jude has been designated as an NCI cancer center since 1977. The hospital was named a comprehensive cancer center in 2008.

A comprehensive cancer center must possess a deep and broad research-based portfolio that extends from the laboratory to the clinic and includes population-based science. Centers must also be actively engaged in professional and public cancer education and outreach.

"We are honored to once again receive this recognition, especially to receive a score of "exceptional"the highest the NCI awards to cancer centers," said Richard Gilbertson, M.D., Ph.D., St. Jude Comprehensive Cancer Center director. "St. Jude has been an NCI-designated cancer center for almost 40 years. Throughout this time, we have served as a national resource for children with cancer, their families and physicians. From the first pipette that's picked up in the lab to the last child treated in the clinic at the end of the day, everything is focused on our patients. We are driven by a common goal to find cures for all children with cancer."

"The efforts of our more than 160 clinicians and scientists are incredible," Gilbertson said. "During the last five years, we have made more than 32,500 patient enrollments to clinical studies. In the year prior to our NCI renewal, we ran 166 cancer clinical trials, including 36 brand new studies. In addition to the children we treat at St. Jude, we provide thousands of free patient consultations each year for children around the world. These are frequently complex and involve extensive histopathology, imaging and clinical chart reviews. In keeping with the ethos of St. Jude, no payment is requested for any consultation."

At St. Jude, the Comprehensive Cancer Center is organized as five cross-disciplinary, multi-departmental programs aligned to specific diseases and research conceptsDevelopmental Biology and Solid Tumor Program; Neurobiology and Brain Tumor Program; Hematological Malignancies Program; Cancer Prevention and Control Program; and the Cancer Genetics, Biochemistry and Cell Biology Program. The availability of 10 centralized shared resources with well-equipped facilities support the design, implementation, analysis, interpretation and reporting of research.

"The Comprehensive Cancer Center at St. Jude is at the very heart of our institution, bringing people together to accelerate science and facilitate the translation of discoveries from the laboratory to the clinic to develop innovative new treatments," said Dr. William E. Evans, St. Jude director and CEO. "To be given an 'exceptional' rating after such a comprehensive and rigorous peer-review process is truly meaningful and extremely gratifying."

"Spurred on by this honor from the NCI, the St. Jude Comprehensive Cancer Center is poised more than ever before to leverage our exciting discoveries and resources to bring new treatments and hope to all children with cancer," Gilbertson said.


'/>"/>

Contact: Carrie Strehlau
carrie.strehlau@stjude.org
901-595-2295
St. Jude Children's Research Hospital
Source:Eurekalert

Related medicine news :

1. CHOC researchers identify technique to reduce childrens post-op pain after high-risk surgery
2. Vibrant Nutraceuticals Announces Launch of Vegan Childrens’ Probiotic, KidsLac
3. Benaroya Research Institute scientists identify drivers of rheumatoid arthritis
4. Researchers uncover common heart drugs link to diabetes
5. EULAR driving research and innovation in rheumatic and RMDs in Europe
6. Mayo Clinic researchers discover new form of cancer
7. UCL licences research to Collagen Solutions for next generation collagen products
8. Researchers recast addiction as a manageable disease
9. Mount Sinai researchers identify protein that keeps blood stem cells healthy as they age
10. The Academy of Radiology Research featured in Nature Biotechnology journal
11. Berkeley Lab researchers create nanoparticle thin films that self-assemble in 1 minute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... ... conference will prominently feature 150+ Hospital and Health System Executive Speakers including: , ... 43rd President of the United States of America: George W. Bush , ... the Ring: Sugar Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber McGraw Walsh ...
(Date:3/23/2017)... ... , ... Sharon Kleyne, host of the nationally syndicated radio program, The Sharon ... talked on her program about how she is looking forward to World Water Day ... important distinction. World Water Day, Kleyne pointed out, is an occasion for looking ahead ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... that help improve all aspects of people’s health and nutrition, announced its product ... products. , Natural Subsistence develops nutritional supplements that help people improve all ...
(Date:3/23/2017)... ... March 23, 2017 , ... Inflow IQ & Inflownomics ... serious so build on a solid foundation. As experts in dangerous situations the ... that is coming soon. Inflownomics deliver ripe, fresh, clean & refreshing knowledge systems that ...
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of Quality Assurance and Utilization ... ABQAURP’s dedication to Health Care Quality and Management and Patient Safety. , It is ... the association, but also to the Health Care Quality and Patient Safety movements. Diplomates ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 2017  Drug diversion is a significant contributing ... overdoses. A new oral fluid monitoring test, announced ... reports more detailed and actionable information to clinicians ... therapy adherence, patient safety, and help to identify ... fluid Rx Evaluation (CORE) system is the first ...
(Date:3/23/2017)...  A new genetic test has been discovered ... who carry HLA-B*15:02 and who are ... deadly side effect of certain medications used to ... HLA-B*15:02 is strongly associated with life-threatening severe ... toxic epidermal necrolysis in patients treated with carbamazepine ...
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... devices market exhibits a consolidated vendor landscape with the ... the overall market in 2015. These companies are ... Industries, Inc., Hygia Health Services, Inc., and VANGUARD ... global reprocessed medical devices market is witnessing the ...
Breaking Medicine Technology: